Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

AstraZeneca PLC

AstraZeneca PLC

AZNCF · PINK
AZNCF · PINK

Next Earnings: 29 Jul 2025

141.90
USD2.201.57%

Latest News

    MarketWatch

    AstraZeneca to build new Virginia plant as it re-hashes other U.S. investment plans

      Forexlive

      AstraZeneca will invest US$50bn in the US to expand manufacturing and research

        MarketWatch

        AstraZeneca shares show signs of life after successful trials of hypertension drug

          CNBC

          FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - CNBC

            @Reuters
            Reuters

            AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year. https://t.co/b5hOwTxWaU https://t.co/Wq5EsZGLK5

              SeekingAlpha

              AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              138.00USD
              141.90USD

              52 Week Range

              120.64USD
              175.00USD

              Market Cap

              221.9BUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              PINK

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              GB0009895292

              CUSIP

              -

              Sector

              Healthcare

              Industry

              Drug Manufacturers - General

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              28.55

              PEG Ratio

              0.95

              Book Value

              26.48

              Dividend Share

              3.1

              Dividend Yield

              2.22%

              Earnings Share

              4.97

              Wall Street Target Price

              -

              EPS Estimate Current Year

              -

              EPS Estimate Next Year

              -

              EPS Estimate Current Quarter

              0

              EPS Estimate Next Quarter

              0

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              54,982,000,640

              Gross Profit TTM

              45,328,998,400

              EBITDA

              18,276,999,168

              Profit Margin

              14.14%

              Return On Assets TTM

              8.16%

              Return On Equity TTM

              19.79%

              Revenue Per Share TTM

              35.467

              Qtly Revenue Growth YOY

              7.20%

              Diluted Eps TTM

              4.97

              Qtly Earnings Growth YOY

              33.60%

              Valuation

              Trailing PE

              28.55

              Forward PE

              15

              Price Sales TTM

              4.0009

              Price Book MRQ

              5.3602

              Enterprise Value Revenue

              4

              Enterprise Value EBITDA

              15

              Peers analysis

              • AstraZeneca PLC ADR
                AZNAstraZeneca PLC ADR

                70.70

                2.88%
              • Novo Nordisk A/S
                NVONovo Nordisk A/S

                68.65

                2.82%
              • Roche Holding Ltd ADR
                RHHBYRoche Holding Ltd ADR

                40.23

                1.11%
              • Novartis AG ADR
                NVSNovartis AG ADR

                117.76

                0.76%
              • Eli Lilly and Company
                LLYEli Lilly and Company

                778.17

                0.31%
              • Johnson & Johnson
                JNJJohnson & Johnson

                168.13

                0.14%
              • AbbVie Inc
                ABBVAbbVie Inc

                187.16

                0.13%
              • Roche Holding AG
                RHHBFRoche Holding AG

                337.00

                0.07%
              • Novartis AG
                NVSEFNovartis AG

                114.52

                -3.52%
              • Roche Holding AG Participation
                RHHVFRoche Holding AG Participation

                317.30

                -1.29%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is AstraZeneca PLC stock price today?

              What is AstraZeneca PLC stock ticker?

              Is AZNCF stock price going up?

              What is the analyst recommendation for AZNCF?

              What is AZNCF market cap?

              Does AZNCF release financial reports?

              When is AZNCF next earnings date?

              What were AZNCF Earnings for the last quarter?

              What was AZNCF Revenue for the last quarter?

              What was AZNCF Net Income for the last quarter?

              Does AZNCF pay dividends?

              How many employees does AZNCF have?

              What is AZNCF EBITDA?

              How to buy AZNCF stocks?

              Should I invest in AZNCF stock?